The Impact of COVID-19 Pandemic on Treatment, Follow-up and Behavioral Characteristics of Chronic Viral Hepatitis Patients

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL
E. M. Saricaoğlu, B. Kayaaslan, Rahmet Güner
{"title":"The Impact of COVID-19 Pandemic on Treatment, Follow-up and Behavioral Characteristics of Chronic Viral Hepatitis Patients","authors":"E. M. Saricaoğlu, B. Kayaaslan, Rahmet Güner","doi":"10.4274/vhd.galenos.2020.2019.0019","DOIUrl":null,"url":null,"abstract":"Objectives: It has been not yet fully understood whether chronic liver diseases may be considered as risk factors for critical course of Coronavirus disease-2019 (COVID-19) Considering the importance of managing with COVID-19, we aimed to investigate the impact of the COVID-19 pandemic on treatment, follow-up and behavioral characteristics of chronic viral hepatitis (CVH) patients Materials and Methods: Patients followed-up in our clinic with diagnosis of chronic hepatitis B or C were screened retrospectively and a total 213 adults included in the study We performed a telephone survey with patients Results: The mean age of participants was 49 9±13 4 years Of the participants, 62% were male Totally 75 (35 2%) patients disrupted their follow-up visits due to COVID-19 pandemic The only risk factor for disruption in follow-up was found as anxiety The vast majority of CVH patients paid attention to prevention measures for COVID-19 Conclusion: We can say that CVH patients' awareness about COVID-19 and application of control measures were well enough Continuity of treatment can be provided in patients with chronic illness during crisis period with informing patients in a way not to cause anxiety and efficient implementations in healthcare system","PeriodicalId":42346,"journal":{"name":"Viral Hepatit Dergisi-Viral Hepatitis Journal","volume":"24 1","pages":"98-103"},"PeriodicalIF":0.2000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Viral Hepatit Dergisi-Viral Hepatitis Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/vhd.galenos.2020.2019.0019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: It has been not yet fully understood whether chronic liver diseases may be considered as risk factors for critical course of Coronavirus disease-2019 (COVID-19) Considering the importance of managing with COVID-19, we aimed to investigate the impact of the COVID-19 pandemic on treatment, follow-up and behavioral characteristics of chronic viral hepatitis (CVH) patients Materials and Methods: Patients followed-up in our clinic with diagnosis of chronic hepatitis B or C were screened retrospectively and a total 213 adults included in the study We performed a telephone survey with patients Results: The mean age of participants was 49 9±13 4 years Of the participants, 62% were male Totally 75 (35 2%) patients disrupted their follow-up visits due to COVID-19 pandemic The only risk factor for disruption in follow-up was found as anxiety The vast majority of CVH patients paid attention to prevention measures for COVID-19 Conclusion: We can say that CVH patients' awareness about COVID-19 and application of control measures were well enough Continuity of treatment can be provided in patients with chronic illness during crisis period with informing patients in a way not to cause anxiety and efficient implementations in healthcare system
新冠肺炎疫情对慢性病毒性肝炎患者治疗、随访及行为特征的影响
目的:慢性肝脏疾病是否可能被视为冠状病毒病-2019 (COVID-19)危重病程的危险因素尚未完全了解。考虑到COVID-19管理的重要性,我们旨在探讨COVID-19大流行对慢性病毒性肝炎(CVH)患者治疗、随访和行为特征的影响。我们对门诊诊断为慢性乙型或丙型肝炎的患者进行回顾性筛查,共纳入213名成年人。我们对患者进行了电话调查。参与者的平均年龄为49.9±13.4岁,男性占62%,共有75例(35.2%)患者因COVID-19大流行而中断随访,唯一中断随访的危险因素为焦虑。绝大多数CVH患者注意COVID-19的预防措施。可以说,CVH患者对COVID-19的认知和控制措施的应用是足够好的,可以在危机期间为慢性病患者提供连续性治疗,以不引起患者焦虑的方式告知患者,并在医疗保健系统中有效实施
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Viral Hepatit Dergisi-Viral Hepatitis Journal
Viral Hepatit Dergisi-Viral Hepatitis Journal MEDICINE, GENERAL & INTERNAL-
自引率
0.00%
发文量
17
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信